These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11941331)

  • 1. Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma.
    Szefler SJ; Eigen H
    J Allergy Clin Immunol; 2002 Apr; 109(4):730-42. PubMed ID: 11941331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.
    Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B
    Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-daily budesonide inhalation suspension in infants and children < 4 and > or = 4 years of age with persistent asthma.
    Scott MB; Ellis MH; Cruz-Rivera M; Fitzpatrick S; Smith JA
    Ann Allergy Asthma Immunol; 2001 Dec; 87(6):488-95. PubMed ID: 11770696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of nebulized budesonide inhalation suspension in a child with asthma.
    Skoner DP; Angelini BL; Friday G; Gentile D
    J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):210-4. PubMed ID: 10518848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma.
    Shapiro G; Mendelson L; Kraemer MJ; Cruz-Rivera M; Walton-Bowen K; Smith JA
    J Allergy Clin Immunol; 1998 Nov; 102(5):789-96. PubMed ID: 9819296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of budesonide inhalation suspension in infants and young children with persistent asthma. Budesonide Inhalation Suspension Study Group.
    Mellon M
    J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):191-9. PubMed ID: 10518846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders.
    Hvizdos KM; Jarvis B
    Drugs; 2000 Nov; 60(5):1141-78. PubMed ID: 11129126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of budesonide inhalation suspension: a nebulizable corticosteroid for persistent asthma in infants and young children.
    White MV; Cruz-Rivera M; Walton-Bowen K
    Fam Med; 1999 May; 31(5):337-45. PubMed ID: 10407712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children.
    Kemp JP; Skoner DP; Szefler SJ; Walton-Bowen K; Cruz-Rivera M; Smith JA
    Ann Allergy Asthma Immunol; 1999 Sep; 83(3):231-9. PubMed ID: 10507269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma.
    Mellon M; Leflein J; Walton-Bowen K; Cruz-Rivera M; Fitzpatrick S; Smith JA
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):593-8. PubMed ID: 10934092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma.
    Scott MB; Skoner DP
    J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):200-9. PubMed ID: 10518847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma control in pediatric patients treated with once-daily or twice-daily nebulized budesonide inhalation suspension (Pulmicort Respules).
    Baker JW; Kemp J; Uryniak T; Silkoff PE
    Allergy Asthma Proc; 2008; 29(3):280-5. PubMed ID: 18534086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily inhaled budesonide for the treatment of asthma: clinical evidence and pharmacokinetic explanation.
    Selroos O; Edsbäcker S; Hultquist C
    J Asthma; 2004; 41(8):771-90. PubMed ID: 15641626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants.
    Baker JW; Mellon M; Wald J; Welch M; Cruz-Rivera M; Walton-Bowen K
    Pediatrics; 1999 Feb; 103(2):414-21. PubMed ID: 9925834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE; Noonan MJ
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of budesonide in moderate to severe asthma.
    O'Connell EJ
    Clin Ther; 2002 Jun; 24(6):887-905; discussion 837. PubMed ID: 12117080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of budesonide in adults and children with mild-to-moderate persistent asthma.
    Banov CH
    J Asthma; 2004 Feb; 41(1):5-17. PubMed ID: 15046373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing inhaled corticosteroid therapy in children with chronic asthma.
    O'Connell EJ
    Pediatr Pulmonol; 2005 Jan; 39(1):74-83. PubMed ID: 15532098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial.
    Leflein JG; Szefler SJ; Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Smith JA
    Pediatrics; 2002 May; 109(5):866-72. PubMed ID: 11986448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.